Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adjuvant therapy for soft tissue sarcomas

J J Lewis1, F Benedetti

  • 1Department of Surgery, Memorial Sloan-Kettering Cancer Center, Cornell University Medical College, New York, New York 10021, USA.

Surgical Oncology Clinics of North America
|October 6, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Family History and Solar Insolation in Bipolar I Disorder.

Acta psychiatrica Scandinavica·2026
Same author

Dissecting heterogeneity in cortical thickness abnormalities in major depressive disorder: a large-scale ENIGMA MDD normative modelling study.

bioRxiv : the preprint server for biology·2025
Same author

Understanding, predicting, and treating depression in pregnancy to improve mothers' and offspring's mental health outcomes: The HappyMums study.

Brain, behavior, & immunity - health·2025
Same author

Long-term remissions with Gilteritinib in early relapse after allogeneic stem cell transplantation of FLT3/NPM1 mutated acute myeloid leukemia.

Blood cell therapy·2024
Same author

Multiplexed high-throughput immune cell imaging in patients with high-risk triple negative early breast cancer: Analysis from the International Breast Cancer Study Group (IBCSG) Trial 22-00.

European journal of cancer (Oxford, England : 1990)·2024
Same author

Radioimmunotherapy versus autologous hematopoietic stem cell transplantation in relapsed/refractory follicular lymphoma: a Fondazione Italiana Linfomi multicenter, randomized, phase III trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same journal

Small Incisions, Big Impact-Robotic Surgery Is Revolutionizing Cancer Care.

Surgical oncology clinics of North America·2026
Same journal

Minimally Invasive and Robotic Surgery for Cancer.

Surgical oncology clinics of North America·2026
Same journal

TeleSurgery: The Present and the Future for Minimally Invasive and Robotic Surgery.

Surgical oncology clinics of North America·2026
Same journal

Minimally Invasive and Robotic Surgery for Rectal Cancer.

Surgical oncology clinics of North America·2026
Same journal

Minimally Invasive/Robotic Surgery for Colon Cancer.

Surgical oncology clinics of North America·2026
Same journal

Minimally Invasive Surgery in Liver Transplantation.

Surgical oncology clinics of North America·2026
See all related articles

Surgical resection is the primary treatment for soft tissue sarcoma. While adjuvant or neoadjuvant chemotherapy shows promise for specific high-risk sarcoma patients, its role remains under investigation.

Area of Science:

  • Oncology
  • Surgical Oncology
  • Medical Oncology

Background:

  • Soft tissue sarcoma treatment relies primarily on surgical resection with wide margins.
  • Adjuvant radiation or intraoperative brachytherapy can improve local control in high-risk cases.
  • The efficacy of neoadjuvant and adjuvant chemotherapy for sarcoma is still debated.

Purpose of the Study:

  • To evaluate the current role of chemotherapy in soft tissue sarcoma management.
  • To identify patient subpopulations who may benefit from neoadjuvant/adjuvant chemotherapy.
  • To discuss the potential for chemoresponsiveness in high-risk sarcoma patients.

Main Methods:

  • Review of current treatment strategies for soft tissue sarcoma.
  • Analysis of recent meta-analyses and phase II data on chemotherapy.

Related Experiment Videos

  • Identification of criteria for selecting patients for investigational chemotherapy.

    • Main Results:

    • Surgical resection remains the cornerstone of primary therapy for soft tissue sarcoma.
    • Postoperative radiation and intraoperative brachytherapy enhance local control for high-risk patients.
    • A definitive role for adjuvant or neoadjuvant chemotherapy is not yet established, but specific patient groups may benefit.

    Conclusions:

    • While not universally proven, neoadjuvant/adjuvant chemotherapy warrants consideration for select soft tissue sarcoma patients.
    • Patients with a high risk of distant metastasis and potential chemoresponsiveness are candidates for investigational chemotherapy.
    • Further research is needed to clarify the benefits of chemotherapy in specific sarcoma subpopulations.